Follow
Sharon Hassin-Baer
Sharon Hassin-Baer
Neurologist, movement disorders specialist; director, Movement Disorders Institute, Sheba Medical
Verified email at post.tau.ac.il
Title
Cited by
Cited by
Year
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
16482019
Novel PINK1 mutations in early‐onset parkinsonism
Y Hatano, Y Li, K Sato, S Asakawa, Y Yamamura, H Tomiyama, ...
Annals of neurology 56 (3), 424-427, 2004
3732004
Intravenous immunoglobulin treatment in multiple sclerosis Effect on relapses
A Achiron, U Gabbay, R Gilad, S Hassin-Baer, Y Barak, M Gornish, ...
Neurology 50 (2), 398-402, 1998
3641998
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ...
Brain 143 (1), 234-248, 2020
1912020
Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis
G Yahalom, R Tsabari, N Molshatzki, L Ephraty, H Cohen, S Hassin-Baer
Clinical neuropharmacology 36 (3), 78-83, 2013
1312013
Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets
DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ...
JAMA neurology 78 (4), 464-472, 2021
1282021
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis
I Agalliu, M San Luciano, A Mirelman, N Giladi, B Waro, J Aasly, ...
JAMA neurology 72 (1), 58-65, 2015
1252015
SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease
RN Alcalay, V Mallett, B Vanderperre, O Tavassoly, Y Dauvilliers, RYJ Wu, ...
Movement Disorders 34 (4), 526-535, 2019
1092019
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
R Inzelberg, OS Cohen, J Aharon-Peretz, I Schlesinger, ...
Neurology 78 (11), 781-786, 2012
962012
Test–retest reliability of UPDRS‐III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: An argument against multiple baseline assessments
LV Metman, B Myre, N Verwey, S Hassin‐Baer, J Arzbaecher, D Sierens, ...
Movement disorders 19 (9), 1079-1084, 2004
942004
Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson’s Disease
N Kaplan, A Vituri, AD Korczyn, OS Cohen, R Inzelberg, G Yahalom, ...
Journal of Molecular Neuroscience 53, 183-188, 2014
882014
Botulinum toxin injections for children with excessive drooling
S Hassin-Baer, E Scheuer, AS Buchman, I Jacobson, B Ben-Zeev
Journal of child Neurology 20 (2), 120-123, 2005
872005
Clinical characteristics of neuroleptic-induced parkinsonism
S Hassin-Baer, P Sirota, AD Korczyn, TA Treves, B Epstein, H Shabtai, ...
Journal of neural transmission 108, 1299-1308, 2001
872001
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations
Y Hatano, K Sato, B Elibol, H Yoshino, Y Yamamura, V Bonifati, ...
Neurology 63 (8), 1482-1485, 2004
852004
Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
L Krohn, TN Öztürk, B Vanderperre, B Ouled Amar Bencheikh, JA Ruskey, ...
Annals of neurology 87 (1), 139-153, 2020
812020
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism
E Moro, J Volkmann, IR Konig, S Winkler, A Hiller, S Hassin-Baer, ...
Neurology 70 (14), 1186-1191, 2008
812008
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ...
Movement Disorders 34 (4), 460-468, 2019
802019
Neuropsychiatric and cognitive features in autosomal‐recessive early parkinsonism due to PINK1 mutations
L Ephraty, O Porat, D Israeli, OS Cohen, O Tunkel, S Yael, Y Hatano, ...
Movement Disorders 22 (4), 566-569, 2007
802007
Enhanced creative thinking under dopaminergic therapy in Parkinson disease
A Faust‐Socher, YN Kenett, OS Cohen, S Hassin‐Baer, R Inzelberg
Annals of neurology 75 (6), 935-942, 2014
772014
A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders
KJ Ngo, JE Rexach, H Lee, LE Petty, S Perlman, JM Valera, JL Deignan, ...
Human mutation 41 (2), 487-501, 2020
742020
The system can't perform the operation now. Try again later.
Articles 1–20